Skip to main content

Animations

MJFF Publications

6481 - 6490 of 9140 Results
Title
Year
  • Year
  • 2019
  • 2025
  • 2024
  • 2017
  • 2019
  • 2017
  • 2014
  • 2016
  • 2019
  • 2018
  • Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    2019
    Summary Details
    OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 75
  • Summary Details
    OPEN
    Title: GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adv1434
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Multiscale Modeling of Magnetoelectric Nanoparticles for the Analysis of Spatially Selective Neural Stimulation
    Journal Name: Advanced Healthcare Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/adhm.202302871
    Citation Count: 14
  • A Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
    2017
    Summary Details
    OPEN
    Title: A Nigro−Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
    Journal Name: Gastroenterology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1053/j.gastro.2017.08.069
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriers
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.24543
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.438
    Citation Count: 19
  • Summary Details
    OPEN
    Title: New ghrelin agonist, HM01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of Parkinson's disease
    Journal Name: Neurogastroenterology & Motility
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nmo.12459
    Citation Count: 57
  • Summary Details
    OPEN
    Title: LRRK2 Regulates Voltage-Gated Calcium Channel Function
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2016.00035
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Reduced habit-driven errors in Parkinson’s Disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-39294-z
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 77
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.